Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

The drugs related to the highest industry payments were blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand ...

Get detailed information on Apixaban, including pronunciation ... avoid coadministration with strong dual inhibitors. • Discontinuing eliquis in patients without adequate continuous ...

Eliquis (apixaban) is an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Rivaroxaban is the only NAO, with a study that considered interruption of treatment, for apixaban and dabigatran further studies are needed. There are no reports of interaction between rivaroxaban ...